136 related articles for article (PubMed ID: 11167807)
21. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.
Harbo HF; Celius EG; Vartdal F; Spurkland A
Tissue Antigens; 1999 Jan; 53(1):106-10. PubMed ID: 10082437
[TBL] [Abstract][Full Text] [Related]
22. A study of the association between a polymorphism in the CTLA-4 gene and postpartum thyroiditis.
Waterman EA; Watson PF; Lazarus JH; Parkes AB; Darke C; Weetman AP
Clin Endocrinol (Oxf); 1998 Aug; 49(2):251-5. PubMed ID: 9828915
[TBL] [Abstract][Full Text] [Related]
23. Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus.
Hayashi H; Kusaka I; Nagasaka S; Kawakami A; Rokkaku K; Nakamura T; Saito T; Higashiyama M; Honda K; Ishikawa SE
Clin Endocrinol (Oxf); 1999 Dec; 51(6):793-9. PubMed ID: 10619986
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
Nithiyananthan R; Heward JM; Allahabadia A; Franklyn JA; Gough SC
Thyroid; 2002 Jan; 12(1):3-6. PubMed ID: 11842815
[TBL] [Abstract][Full Text] [Related]
25. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients.
Akamizu T; Sale MM; Rich SS; Hiratani H; Noh JY; Kanamoto N; Saijo M; Miyamoto Y; Saito Y; Nakao K; Bowden DW
Thyroid; 2000 Oct; 10(10):851-8. PubMed ID: 11081251
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism affects lymphocyte profiles in bronchoalveolar lavage of patients with sarcoidosis.
Handa T; Nagai S; Ito I; Shigematsu M; Hamada K; Kitaichi M; Izumi T; Mishima M
Sarcoidosis Vasc Diffuse Lung Dis; 2003 Oct; 20(3):190-6. PubMed ID: 14620161
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews.
Mack R; Chowdary D; Samaan P; Podolak I; Dermody J
Genet Test; 2001; 5(3):269-71. PubMed ID: 11788096
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.
Vaidya B; Imrie H; Perros P; Dickinson J; McCarthy MI; Kendall-Taylor P; Pearce SH
Lancet; 1999 Aug; 354(9180):743-4. PubMed ID: 10475192
[TBL] [Abstract][Full Text] [Related]
29. The CTLA-4 gene is associated with multiple sclerosis.
Ligers A; Xu C; Saarinen S; Hillert J; Olerup O
J Neuroimmunol; 1999 Jun; 97(1-2):182-90. PubMed ID: 10408973
[TBL] [Abstract][Full Text] [Related]
30. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.
Dyment DA; Steckley JL; Willer CJ; Armstrong H; Sadovnick AD; Risch N; Ebers GC
J Neuroimmunol; 2002 Feb; 123(1-2):193-8. PubMed ID: 11880164
[TBL] [Abstract][Full Text] [Related]
31. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Diabetes Incidence in Sweden Study Group.
Lowe RM; Graham J; Sund G; Kockum I; Landin-Olsson M; Schaefer JB; Törn C; Lernmark A; Dahlquist G
Autoimmunity; 2000 Oct; 32(3):173-80. PubMed ID: 11092697
[TBL] [Abstract][Full Text] [Related]
32. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Kouki T; Gardine CA; Yanagawa T; Degroot LJ
J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population.
Jun TY; Pae CU; Chae JH; Bahk WM; Kim KS; Han H
Psychiatry Res; 2002 May; 110(1):19-25. PubMed ID: 12007590
[TBL] [Abstract][Full Text] [Related]
34. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
[TBL] [Abstract][Full Text] [Related]
35. CTLA4 exon 1 dimorphism in bullous and cicatricial pemphigoid.
Drouet M; Aupetit C; Delpuget-Bertin N; Bedane C; Bonnetblanc JM; Cogné M
Eur J Immunogenet; 2000 Apr; 27(2):77-9. PubMed ID: 10792422
[TBL] [Abstract][Full Text] [Related]
36. CTLA4 is associated with susceptibility to multiple sclerosis.
Kantarci OH; Hebrink DD; Achenbach SJ; Atkinson EJ; Waliszewska A; Buckle G; McMurray CT; de Andrade M; Hafler DA; Weinshenker BG
J Neuroimmunol; 2003 Jan; 134(1-2):133-41. PubMed ID: 12507781
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians.
Milicic A; Brown MA; Wordsworth BP
Tissue Antigens; 2001 Jul; 58(1):50-4. PubMed ID: 11580858
[TBL] [Abstract][Full Text] [Related]
38. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus.
Liu MF; Wang CR; Lin LC; Wu CR
Lupus; 2001; 10(9):647-9. PubMed ID: 11678454
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
Lupus; 2001; 10(9):601-5. PubMed ID: 11678447
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.
Fukazawa T; Yanagawa T; Kikuchi S; Yabe I; Sasaki H; Hamada T; Miyasaka K; Gomi K; Tashiro K
J Neurol Sci; 1999 Dec; 171(1):49-55. PubMed ID: 10567049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]